Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells.
Kluza J, Jendoubi M, Ballot C, Dammak A, Jonneaux A, Idziorek T, Joha S, Dauphin V, Malet-Martino M, Balayssac S, Maboudou P, Briand G, Formstecher P, Quesnel B, Marchetti P.
Kluza J, et al. Among authors: ballot c.
PLoS One. 2011;6(7):e21924. doi: 10.1371/journal.pone.0021924. Epub 2011 Jul 18.
PLoS One. 2011.
PMID: 21789194
Free PMC article.